Innospec Inc. - Common Stock (IOSP)
80.55
+3.91 (5.10%)
NASDAQ · Last Trade: May 9th, 12:34 PM EDT
Innospec (NASDAQ:IOSP) reported mixed first-quarter 2026 results, as strong performance in its Fuel Specialties segment was partially offset by disruptions tied to a January 2026 U.S. winter storm that affected operations in Performance Chemicals and, to a lesser extent, Oilfield Services. Managemen
Via MarketBeat · May 8, 2026
Innospec (IOSP) Q1 2026 Earnings Transcript
Via The Motley Fool · May 8, 2026
Innospec Inc. (NASDAQ:IOSP) Q1 2025: Revenue Beats Estimates but Earnings Miss as Winter Storms Disrupt Operationschartmill.com
Via Chartmill · May 7, 2026
This medical technology firm provides spinal surgery solutions to U.S. hospitals and surgical centers through proprietary devices.
Via The Motley Fool · May 5, 2026
Innospec Inc. (NASDAQ:IOSP) Passes the "Caviar Cruise" Quality Investing Screenchartmill.com
Via Chartmill · April 21, 2026
Innospec Inc. (NASDAQ:IOSP) Passes the "Caviar Cruise" Quality Investing Screenchartmill.com
Via Chartmill · March 26, 2026
Select Medical Holdings delivers rehabilitation and occupational health services through a nationwide network of hospitals and clinics.
Via The Motley Fool · May 5, 2026
Innospec (IOSP) Q4 2024 Earnings Transcript
Via The Motley Fool · April 20, 2026
Innospec Inc (NASDAQ:IOSP) Passes Key Quality Investing Screenchartmill.com
Via Chartmill · February 25, 2026

Innospec (IOSP) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 18, 2026
Innospec Inc (NASDAQ:IOSP) Reports Mixed Q4 2025 Results with Earnings Beat and Revenue Misschartmill.com
Via Chartmill · February 17, 2026
Via Benzinga · November 18, 2025
Innospec's (NYSE: IOSP) short interest as a percent of float has risen 6.15% since its last report. According to exchange reported data, there are now 334 thousand shares sold short, which is 1.9% of all regular shares that are available for trading.
Via Benzinga · September 25, 2025

Via Benzinga · June 5, 2025
Via Benzinga · April 21, 2025

IOSP stock results show that Innospec beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024

